These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 835599)

  • 1. Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases.
    Von Hoff DD; Rozencweig M; Layard M; Slavik M; Muggia FM
    Am J Med; 1977 Feb; 62(2):200-8. PubMed ID: 835599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cardiotoxicity of adriamycin and daunomycin in children.
    Gilladoga AC; Manuel C; Tan CT; Wollner N; Sternberg SS; Murphy ML
    Cancer; 1976 Feb; 37(2 Suppl):1070-8. PubMed ID: 1253124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for development of daunorubicin cardiotoxicity.
    Von Hoff DD; Layard M
    Cancer Treat Rep; 1981; 65 Suppl 4():19-23. PubMed ID: 7049377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daunomycin: a cardiotoxic agent.
    Ainger LE; Bushore J; Johnson WW; Ito J
    J Natl Med Assoc; 1971 Jul; 63(4):261-7. PubMed ID: 5142139
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on the cardiotoxicity of daunomycin in patients with acute leukemia].
    Marni E; Marchi A; Laini C; Zanol MG; Martini A; Livieri C; Genova R
    Minerva Pediatr; 1978 Feb; 30(4):333-8. PubMed ID: 273716
    [No Abstract]   [Full Text] [Related]  

  • 6. Anthracycline cardiomyopathy in children: report of two cases.
    Mosijczuk AD; Ruymann FB; Mease AD; Bernier RD
    Cancer; 1979 Nov; 44(5):1582-7. PubMed ID: 291472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical spectrum of anthracycline antibiotic cardiotoxicity.
    Bristow MR; Billingham ME; Mason JW; Daniels JR
    Cancer Treat Rep; 1978 Jun; 62(6):873-9. PubMed ID: 667861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echocardiographic assessment of anthracycline cardiotoxicity in children.
    Lewis AB; Pilkington R; Takahashi M; Siegel SE
    Med Pediatr Oncol; 1978; 5(1):167-75. PubMed ID: 745585
    [No Abstract]   [Full Text] [Related]  

  • 9. [Daunomycin-and adriamycin-induced cardiomyopathy--relationship between dosage of drugs and histopathological findings (author's transl)].
    Yamaguchi H; Toyota S; Takahara O; Ichimaru M
    Rinsho Ketsueki; 1978 Aug; 19(8):1041-50. PubMed ID: 713049
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cardiotoxic effect of anthracycline antibiotics].
    Jovanović I; Ceranić LJ; Simeunović S; Cvetković P
    Bilt Hematol Transfuz; 1983; 11(2-3):51-7. PubMed ID: 6680300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for doxorubicin-induced congestive heart failure.
    Von Hoff DD; Layard MW; Basa P; Davis HL; Von Hoff AL; Rozencweig M; Muggia FM
    Ann Intern Med; 1979 Nov; 91(5):710-7. PubMed ID: 496103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term study of anthracycline-induced cardiomyopathy in children and adolescents].
    Koch H; Schmitz L; Brockmeier K; Hartmann R; Bein G; Henze G
    Klin Padiatr; 1991; 203(4):262-7. PubMed ID: 1942932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative evaluation of the cardiotoxic effects of antineoplastic antibiotics adriamycin and pharmorubicin].
    Valvere VIu; Shkhvatsabaia LV; Niu-Tian-de GB
    Kardiologiia; 1989 Sep; 29(9):64-7. PubMed ID: 2687558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time- and dose-dependent changes in ejection fraction after anthracycline therapy.
    Narahara KA; Singer JW; Ritchie JL; Williams DL; Hamilton GW; Kennedy JW
    J Cardiovasc Pharmacol; 1979; 1(4):395-401. PubMed ID: 94617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy-induced cardiotoxicity: Incidence, diagnosis and prevention].
    Nelson-Veniard M; Thambo JB
    Bull Cancer; 2015; 102(7-8):622-6. PubMed ID: 25935231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial studies of cardiac function in patients receiving adriamycin.
    Henderson IC; Sloss LJ; Jaffe N; Blum RH; Frei E
    Cancer Treat Rep; 1978 Jun; 62(6):923-9. PubMed ID: 667869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience.
    Krischer JP; Epstein S; Cuthbertson DD; Goorin AM; Epstein ML; Lipshultz SE
    J Clin Oncol; 1997 Apr; 15(4):1544-52. PubMed ID: 9193351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiotoxicity in long term treatment with cytostatics (author's transl)].
    Fuhrmann U; Rieger M; Franz Ch
    Dtsch Med Wochenschr; 1978 Mar; 103(9):387-90. PubMed ID: 272983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute heart failure after a moderate dose of rubidomycin].
    Baledent M; Messerschmitt J; Bens JL; Quiret JC; Faille N
    Sem Hop; 1972 Feb; 48(7):507-10. PubMed ID: 4338408
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value.
    Skubitz KM; Blaes AH; Konety SH; Francis GS
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):787-798. PubMed ID: 28856562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.